The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry.
The largest deal of the week is Bayer AG‘s acquisition of Asklepios BioPharmaceutical, Inc. for $2 billion upfront and a potential $2 billion in milestones. Asklepios BioPharmaceutical specializes in the research, development and manufacturing of gene therapies across different therapeutic areas, including investigational pre-clinical and clinical-stage candidates for the treatment of neuromuscular, central nervous system, cardiovascular and metabolic diseases. Bayer will own full rights to AskBio’s gene therapy platform, including a broad intellectual property portfolio and an established contract development and manufacturing organization.
To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets.
| Behavioral Health Care | ||
| Acquirer | Target | Price |
| CloudMD Software & Services Inc. | HumanaCare Inc. | $7,623,112 |
| Biotechnology | ||
| Acquirer | Target | Price |
| Bayer AG | Asklepios BioPharmaceutical, Inc. | $2,000,000,000 |
| Jazz Pharmaceuticals plc | FAAH Inhibitor Program | $35,000,000 |
| miRagen Therapeutics, Inc. | Viridian Therapeutics, Inc. | $100,616,000 |
| Novartis AG | Anti-COVID-19 DARPin program | $22,000,000 |
| eHealth | ||
| Acquirer | Target | Price |
| Medidata Solutions | MC10’s digital biomarker business | N/A |
| Teleperformance | Health Advocate | $690,000,000 |
| Ontrak, Inc | LifeDojo Inc | N/A |
| Frazier Healthcare Partners | Accuity Delivery Systems | N/A |
| Hospitals | ||
| Acquirer | Target | Price |
| Keralty Health | Westchester General Hospital, Inc. | N/A |
| Surgery Partners | Bakersfield Heart Hospital | N/A |
| Laboratories, MRI and Dialysis | ||
| Acquirer | Target | Price |
| Exact Sciences Corp. | Thrive Earlier Detection Corp. | $1,700,000,000 |
| Long-Term Care | ||
| Acquirer | Target | Price |
| Regional owner/operator | Arbor Court & The Willows | $2,850,000 |
| Not disclosed | 3 senior living communities | $46,000,000 |
| Medical Devices | ||
| Acquirer | Target | Price |
| Cerberus Capital Management, LP | National Dentex Labs | N/A |
| Teleflex Incorporated | Z-Medica, LLC | $500,000,000 |
| Physician Medical Groups | ||
| Acquirer | Target | Price |
| Infratil Limited and Morrison & Co Growth Infrastructure Fund | Qscan Group Holdings Pty. Ltd. | $294,620,000 |
| Schweiger Dermatology Group | Harkaway Center for Dermatology and Aesthetics | N/A |
| Other Services | ||
| Acquirer | Target | Price |
| Syneos Health, Inc. | Synteract Inc. | $400,000,000 |
